Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: Insights into clinical features and outcomes

Arthritis Research and Therapy

Volumn 9, Issue 4, 2007, Pages

  Koenig, Martial ^a   Fritzler, Marvin J ^b   Targoff, Ira N ^c,d   Troyanov, Yves ^a   Senécal, Jean Luc ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; FIBRILLARIN ANTIBODY; JO 1 ANTIBODY; KU ANTIBODY; PM SCL ANTIBODY; PROTEIN A; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCLERODERMA AUTOANTIGEN; SYNTHETASE ANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; EPITOPE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; IN VITRO STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYOSITIS; PREVALENCE; ADOLESCENT; ADULT; BLOOD; CROSS-SECTIONAL STUDY; EPITOPE MAPPING; IMMUNOLOGY;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; AUTOIMMUNE DISEASES; CROSS-SECTIONAL STUDIES; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNOASSAY; MYOSITIS;

EID: 34548730352     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2276     Document Type: Article

References (53)

1. Nagaraju K Plotz PH Miller FW Inflammatory muscle disease: Etiology and pathogenesis Rheumatology ELSEVIER, Toronto, Canada Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH 2003, 1523-535 13130145
2. Targoff IN Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies Rheum Dis Clin North Am 2002, 28:859-890 10.1016/S0889-857X(02)00032-7 12506776
3. Bohan A Peter JB Polymyositis and dermatomyositis (first of two parts) N Engl J Med 1975, 292:344-347 1090839
4. Bohan A Peter JB Polymyositis and dermatomyositis (second of two parts) N Engl J Med 1975, 292:403-407 1089199
5. Amato AA Griggs RC Unicorns, dragons, polymyositis, and other mythological beasts Neurology 2003, 61:288-289 12913184
6. Miller FW Rider LG Plotz PH Isenberg DA Oddis CV Diagnostic criteria for polymyositis and dermatomyositis Lancet 2003, 362:1762-1763 author reply 1763. 10.1016/S0140-6736(03)14862-3 14643132
7. Targoff IN Miller FW Medsger TA Jr Oddis CV Classification criteria for the idiopathic inflammatory myopathies Curr Opin Rheumatol 1997, 9:527-535 10.1097/00002281-199711000-00008 9375282
8. van der Meulen MF Bronner IM Hoogendijk JE Burger H van Venrooij WJ Voskuyl AE Dinant HJ Linssen WH Wokke JH de Visser M Polymyositis: An overdiagnosed entity Neurology 2003, 61:316-321 12913190
9. Medsger TA Jr Oddis CV Classification and diagnostic criteria for polymyositis and dermatomyositis J Rheumatol 1995, 22:581-585 7791146
10. Love LA Leff RL Fraser DD Targoff IN Dalakas M Plotz PH Miller FW A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups Medicine (Baltimore) 1991, 70:360-374 1659647
11. Kissel JT Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies Semin Neurol 2002, 22:41-51 10.1055/s-2002-33047 12170392
12. Oddis CV Medsger TA Jr Inflammatory muscle disease: Clinical features Rheumatology ELSEVIER, Toronto, Canada Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH 2003, 1537-1554
13. Venables PJ Polymyositis-associated overlap syndromes Br J Rheumatol 1996, 35:305-308 10.1093/rheumatology/35.4.305 8624632
14. Troyanov Y Targoff I Tremblay JL Goulet JR Raymond Y Senécal JL Novel classification of idiopathic inflammatory myopathies based on overlap clinical features and autoantibodies: Analysis of 100 French Canadian patients with myositis Medicine 2005, 84:231-249 10.1097/ 01.md.0000173991.74008.b0 16010208
15. Targoff IN Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine: Two additional synthetases are antigenic in myositis J Immunol 1990, 144:1737-1743 2307838
16. Targoff IN Trieu EP Miller FW Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase J Clin Invest 1993, 91:2556-2564 443318 8514867
17. Arnett FC Targoff IN Minori T Goldstein R Warner NB Reveille JD Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis Arthritis Rheum 1996, 39:1507-1518 10.1002/art.1780390910 8814062
18. Scussel-Lonzetti L Joyal F Raynauld JP Roussin A Rich E Goulet JR Raymond Y Senécal JL Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival Medicine (Baltimore) 2002, 81:154-167 10.1097/00005792-200203000-00005 11889414
19. Mitri GM Lucas M Fertig N Steen VD Medsger TA Jr A comparison between anti-Th/To- and anti-centromere antibody-positive systemic sclerosis patients with limited cutaneous involvement Arthritis Rheum 2003, 48:203-209 10.1002/art.10760 12528120
20. Kuwana M Okano Y Pandey JP Silver RM Fertig N Medsger TA Jr Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: Analytical accuracy and clinical associations in systemic sclerosis Arthritis Rheum 2005, 52:2425-2432 10.1002/art.21232 16052583
21. Marguerie C Bunn CC Copier J Bernstein RM Gilroy JM Black CM So AK Walport MJ The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl Medicine (Baltimore) 1992, 71:327-336 1435228
22. Burdt MA Hoffman RW Deutscher SL Wang GS Johnson JC Sharp GC Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings Arthritis Rheum 1999, 42:899-909 10.1002/ 1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L 10323445
23. Okano Y Steen VD Medsger TA Jr Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis Arthritis Rheum 1992, 35:95-100 10.1002/art.1780350114 1731817
24. Tormey VJ Bunn CC Denton CP Black CM Anti-fibrillarin antibodies in systemic sclerosis Rheumatology 2001, 40:1157-1162 10.1093/rheumatology/ 40.10.1157 11600746
25. Okano Y Targoff IN Oddis CV Fujii T Kuwana M Tsuzaka K Hirakata M Minori T Craft J Medsger TA Jr Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: A rare anti-U snRNP specificity Clin Immunol Immunopathol 1996, 81:41-47 10.1006/clin.1996.0155 8808640
26. Cooley HM Melny BJ Gleeson R Greco T Kay TW Clinical and serological associations of anti-Ku antibody J Rheumatol 1999, 26:563-567 10090163
27. Targoff IN Johnson AE Miller FW Antibody to signal recognition particle in polymyositis Arthritis Rheum 1990, 33:1361-1370 10.1002/ art.1780330908 2403400
28. Dagenais A Bibor-Hardy V Senécal JL A novel autoantibody causing a peripheral fluorescent antinuclear antibody pattern is specific for nuclear pore complexes Arthritis Rheum 1988, 31:1322-1327 10.1002/ art.1780311017 3052460
29. Wilken N Kossner U Senécal JL Scheer U Dabauvalle MC Nup180, a novel nuclear pore complex protein localizing to the cytoplasmic ring and associated fibrils J Cell Biol 1993, 123:1345-1354 10.1083/ jcb.123.6.1345 8253835
30. Targoff IN Reichlin M The association between Mi-2 antibodies and dermatomyositis Arthritis Rheum 1985, 28:796-803 10.1002/art.1780280711 2409985
31. Vignali DA Multiplexed particle-based flow cytometric assays J Immunol Methods 2000, 21: 243-255 10.1016/S0022-1759(00)00238-6
32. Fritzler MJ Advances and applications of multiplexed diagnostic technologies in autoimmune diseases Lupus 2006, 15:422-427 10.1191/ 0961203306lu2327oa 16898176
33. Euroimmun http://www.euroimmun.com
34. Hénault J Tremblay M Clément I Raymond Y Senécal JL Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis Arthritis Rheum 2004, 50:3265-2274 10.1002/art.20515 15476238
35. Vazquez-Abad D Wallace S Senécal JL Joyal F Roussin A Earnshaw WC Rothfield N Anti-centromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen Arthritis Rheum 1994, 37:248-252 10.1002/art.1780370214 8129780
36. Eystathioy T Chan EKL Yang Z Takeuchi K Mahler M Luft LM Zochodne DW Fritzler MJ Clinical and serological associations of autoantibodies to a novel cytoplasmic autoantigen, GW182 and GW bodies J Mol Med 2003, 81:811-818 10.1007/s00109-003-0495-y 14598044
37. Arnett FC Reveille JD Goldstein R Pollard KM Leaird K Smith EA Leroy EC Fritzler MJ Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serological, and clinical analysis Arthritis Rheum 1996, 39:1151-1160 10.1002/art.1780390712 8670324
38. Yang JM Hildebrandt B Luderschmidt C Pollard KM Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex Arthritis Rheum 2003, 48:210-217 10.1002/art.10729 12528121
39. Takeuchi K Turley SJ Tan EM Pollard KM Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity J Immunol 1995, 154:961-971 7529293
40. Rutjes SA Vree Egberts WT Jongen P Van Den Hoogen F Pruijn GJ Van Venrooij WJ Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy Clin Exp Immunol 1997, 109:403-405 1904762 9328112 10.1046/ j.1365-2249.1997.4081308.x
41. Yaneva M Arnett FC Antibodies against Ku protein in sera from patients with autoimmune diseases Clin Exp Immunol 1989, 76:366-372 1541894 2665976
42. Brouwer R Hengstman GJ Vree Egberts W Ehrfeld H Bozic B Ghirardello A Grondal G Hietarinta M Isenberg D Kalden JR Autoantibody profiles in the sera of European patients with myositis Ann Rheum Dis 200,1 60:116-123 1753477 11156543 10.1136/ard.60.2.116
43. Hausmanowa-Petrusewicz I Kowalska-Oledzka E Miller FW Jarzabeck-Chorzelzka M Targoff IN Blaszczyk-Kostanecka M Jablonska S Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies Arthritis Rheum 1997, 40:1257-1266 9214426
44. Ghirardello A Zampieri S Tarricone E Iaccarino L Bendo R Briani C Rondinone R Sarzi-Puttini P Todesco S Doria A Clinical implications of autoantibody screening in patients with autoimmune myositis Autoimmunity 2006, 39:217-221 10.1080/08916930600622645 16769655
45. Ghirardello A Zampieri S Iaccarino L Tarricone E Tonello M Bendo R Rondinone R Cozzi F Doria A Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: A serologic study of 46 patients Reumatismo 2005, 57:22-28 15776143
46. Hirakata M Mimori T Akizuki M Craft J Hardin JA Homma M Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease Arthritis Rheum 1992, 35:449-456 10.1002/art.1780350415 1567494
47. Wang J Satoh M Kabir F Shaw M Domingo MA Mansoor R Behney KM Dong X Lahita RG Richards HB Reeves WH Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus Arthritis Rheum 2001, 44:2367-2370 10.1002/ 1529-0131(200110)44:10<2367::AID-ART400>3.0.CO;2-I 11665978
48. Goldstein R Sengar DP Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus Arthritis Rheum 1993, 36:1121-1127 10.1002/art.1780360813 8343187
49. Steen V Autoantibodies in systemic sclerosis Semin Arthritis Rheum 2005, 35:35-42 10.1016/j.semarthrit.2005.03.005 16084222
50. Reichlin M Arnett FC Jr Multiplicity of antibodies in myositis sera Arthritis Rheum 1984, 27:1150-1156 10.1002/art.1780271011 6386003
51. Fritzler MJ Behmanesh F Fritzler ML Analysis of human sera that are polyreactive in an addressable laser bead immunoassay Clin Immunol 2006, 120:349-536 10.1016/j.clim.2006.03.007 16644287
52. Hengstman GJ Vree Egberts WT Seelig HP Lundberg IE Moutsopoulos HM Doria A Mosca M Vencovsky J van Venrooij WJ van Engelen BG Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen Ann Rheum Dis 2006, 65:242-245 10.1136/ard.2005.040717 16410528
53. Ge Q Nilasena DS O'Brien CA Frank MB Targoff IN Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen J Clin Invest 1995, 96:1730-1737 185809 7560064